chr22-32498414-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012179.4(FBXO7):c.1453G>C(p.Val485Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V485I) has been classified as Uncertain significance.
Frequency
Consequence
NM_012179.4 missense
Scores
Clinical Significance
Conservation
Publications
- parkinsonian-pyramidal syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_012179.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FBXO7 | NM_012179.4 | MANE Select | c.1453G>C | p.Val485Leu | missense | Exon 9 of 9 | NP_036311.3 | ||
| FBXO7 | NM_001033024.2 | c.1216G>C | p.Val406Leu | missense | Exon 9 of 9 | NP_001028196.1 | |||
| FBXO7 | NM_001257990.2 | c.1111G>C | p.Val371Leu | missense | Exon 9 of 9 | NP_001244919.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FBXO7 | ENST00000266087.12 | TSL:1 MANE Select | c.1453G>C | p.Val485Leu | missense | Exon 9 of 9 | ENSP00000266087.7 | ||
| FBXO7 | ENST00000452138.3 | TSL:2 | c.1216G>C | p.Val406Leu | missense | Exon 9 of 9 | ENSP00000388547.2 | ||
| FBXO7 | ENST00000397426.5 | TSL:2 | c.1111G>C | p.Val371Leu | missense | Exon 9 of 9 | ENSP00000380571.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461888Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Parkinsonian-pyramidal syndrome Uncertain:1
This sequence change replaces valine with leucine at codon 485 of the FBXO7 protein (p.Val485Leu). The valine residue is moderately conserved and there is a small physicochemical difference between valine and leucine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with FBXO7-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at